Magnus Ingelman Sundberg's Biography

Magnus Ingelman Sundberg, Professor/Head, Karolinska Institutet

Magnus Ingelman-Sundberg is a PhD and BSc.Med. He is Chairman of the Editorial Board of Pharmacogenetics and Genomics and Chairman of the Microsomes and Drug Oxidation organisation. He has been working with pharmacogenomics at EMA (PGWP) since 2005. He has 350 original papers, 17 500 citations and an h-factor of 72. He is ranked as the 4th most highly impact researcher in the field of drug metabolism (www.cytochrome.net ) and one of the worlds most cited authors within the category Pharmacology http://isihighlycited.com/ . The current research is centered about genetic predictors for drug response and adverse drug reactions.

New Developments in Pharmacogenomics and Drug Safety

Tuesday, 13 March 2012 at 09:00

Add to Calendar ▼2012-03-13 09:00:002012-03-13 10:00:00Europe/LondonNew Developments in Pharmacogenomics and Drug SafetyADME and Predictive Toxicology Europe in Munich, GermanyMunich, GermanySELECTBIOenquiries@selectbiosciences.com

The lecture will give an update in the field of current and future pharmacogenomic biomarkers of importance for prediction of drug metabolism, drug action and adverse drug reactions focusing on the most clinically relevant examples.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonADME and Predictive Toxicology EuropeADME and Predictive Toxicology Europe in Munich, GermanyMunich, GermanySELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors